{"id":"tacalcitol-ointment","safety":{"commonSideEffects":[{"rate":"null","effect":"Skin irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By activating the vitamin D receptor, tacalcitol ointment influences the expression of genes involved in cell differentiation and proliferation, leading to its therapeutic effects.","oneSentence":"Tacalcitol ointment is a synthetic vitamin D3 analog that modulates the vitamin D receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:37:22.102Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of psoriasis"}]},"trialDetails":[{"nctId":"NCT00670241","phase":"PHASE3","title":"Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2008-04","conditions":"Psoriasis Vulgaris","enrollment":458},{"nctId":"NCT00640822","phase":"PHASE3","title":"Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment Compared With Tacalcitol Ointment in Patients With Psoriasis on the Face and Skin Folds","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2008-02","conditions":"Psoriasis Vulgaris","enrollment":782}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ADRENAL SUPPRESSION"},{"count":1,"reaction":"BLOOD CORTICOTROPHIN DECREASED"},{"count":1,"reaction":"C-REACTIVE PROTEIN INCREASED"},{"count":1,"reaction":"CUSHING'S SYNDROME"},{"count":1,"reaction":"DIABETES MELLITUS INSULIN-DEPENDENT"},{"count":1,"reaction":"DRUG INEFFECTIVE"},{"count":1,"reaction":"GENERAL PHYSICAL HEALTH DETERIORATION"},{"count":1,"reaction":"HYPERTENSION"},{"count":1,"reaction":"LEUKOCYTOSIS"},{"count":1,"reaction":"PSORIASIS"}],"_approvalHistory":[],"publicationCount":47,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Tacalcitol ointment","genericName":"Tacalcitol ointment","companyName":"LEO Pharma","companyId":"leo-pharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tacalcitol ointment is a small molecule used to treat Psoriasis Vulgaris. It is a synthetic derivative of vitamin D3, specifically 1,24-dihydroxyvitamin D3.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}